Nucleus 5 Smallest Cochlear Implant Gets US OK

Posted by admin in Health/Technology on 09 8th, 2009 | no responses

Cochlear , Ltd (Lane Cove, NSW, Australia) has won FDA approval to market the Nucleus 5 device for people with severe-to-profound hearing loss. The titanium device is the smallest of its kind. Nucleus 5 sports a two way remote control, telephone connectivity, and proprietary sound processing technology. Smallest sound processor — for a comfortable and discreet fit. The Nucleus 5 Sound Processor is smaller than any other and designed to fit comfortably and securely. Yet, it is tough and secure enough for any situation. Features the most flexible options to anticipate your needs – from an extensive selection of wearable options for every age and lifestyle, to music, phone and entertainment accessories and easy connection options, we’ve anticipated your everyday needs. Thinnest titanium implant design — Ideal choice for all ages. The Nucleus 5 System features the thinnest titanium implant in the industry. It is 40% thinner than our previous generation and 30% thinner than any other titanium implant available. Nucleus 5 is the world’s most water

resistant allowing you to relax around water or play by the pool. With the industry’s only International Protection Rating of IP44 18 you have the assurance that your sound processor can keep up with your active lifestyle, even around water. The exclusive two-way remote assistant is an added bonus to your system. Gives you the added flexibility and control of being able to adjust your settings easily from the remote assistant or directly on the sound processor – and gives parents the added peace of mind that their child is hearing their best. Also allows the easiest bilateral use. With the Nucleus 5 System if you have chosen to go bilateral (with cochlear implants for both ears) your two sound processors can be easily and simultaneously controlled with the exclusive two-way remote assistant. Product page : Nucleus 5 … Press release : Cochlear Americas Announces FDA Approval of the Nucleus(R) 5 System